Table of Contents
Chemotherapy Research and Practice
Volume 2014 (2014), Article ID 259312, 6 pages
http://dx.doi.org/10.1155/2014/259312
Clinical Study

Dose-Dense Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Node-Positive Breast Cancer

Department of Radiation & Oncology, Cancer Research Center, Shohadaye-Tajrish Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran

Received 28 April 2014; Revised 28 August 2014; Accepted 28 August 2014; Published 9 September 2014

Academic Editor: Vassilis Georgoulias

Copyright © 2014 Hamid Reza Mirzaei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hamid Reza Mirzaei, Fatemeh Nasrollahi, Ladan Mohammadi Yeganeh, Sepideh Jafari Naeini, Pegah Bikdeli, and Parastoo Hajian, “Dose-Dense Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Node-Positive Breast Cancer,” Chemotherapy Research and Practice, vol. 2014, Article ID 259312, 6 pages, 2014. doi:10.1155/2014/259312